Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

ReNeuron reports positive data from stroke trial

Country: United Kingdom

ReNeuron Plc has reported positive data from a Phase 2 trial of its allogeneic cell therapy for patients disabled by a stroke and plans to apply to regulatory authorities in the US and Europe to begin a pivotal study that could lead to possible registration.

Read more

TiGenix plans US initial public offering

Country: Belgium

The cell-therapy company TiGenix NV has announced plans to make an initial public offering of its shares on the Nasdaq exchange in the US in order to raise money for the clinical development of its portfolio. The company is already listed on Euronext Brussels.

Read more

Novartis says CTL019 achieved remission in 82% of patients

Country: United States

Read more

Jardiance approved for new indication

Country: United States

Read more

Genome sequenced using hand-held device

Country: United Kingdom

Read more

Actelion, Johnson & Johnson confirm talks

Country: Switzerland

Read more

Eli Lilly Alzheimer’s drug fails

Country: United States

Read more

Two more deaths in Juno immunotherapy trial

Country: United States

Read more

Meeting report: regulating the new cancer therapies

Country: United Kingdom

Read more

Kite outlines regulatory plans

Country: United States

Read more

Novartis acquires Selexys

Country: Switzerland

Read more

Safety mechanism for autoimmunity

Country: Sweden

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Cheap capital gives rise to integrated pharma R&D by John Rountree

CommentaryJohnRountreeNov-Dec2016.pdf

Highlights of the November/December 2016 MedNous issue

The November/December 2016 MedNous features:

Latest Mednous cover
  • Antibiotic Review
    New approaches to antibiotic development
  • Oncology Development
    Many first-in-class compounds reach late-stage development
    By Bruno Pagliara
  • Commentary
    Cheap capital gives rise to integrated R&D
    By John Rountree
  • Regenerative Medicine
    Regulators discuss cell-based cancer immunotherapies
  • Commentary
    Thought disruption in R&D discovery
    By Tony Sedgwick
  • Clinical Research
    Setbacks for Lilly and Juno

The latest MedNous journal. Subscribe to download.

Recent Appointments

Neil Miller named CEO at Auspherix
Jörg Vollmer becomes CSO at Rigontec
Irina Antonijevic becomes CMO at vasopharm
Christophe Bonny joins Enterome